Quitting smoking is one of the best things you can do for your health. It can improve your health immediately and continue to improve it for years to come. Here are some of the advantages of quitting smoking👇 More info: bit.ly/46dYoIZ #quitsmoking #stopsmoking #health

First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion–Positive NSCLC | NEJM nejm.org/doi/full/10.10…

Nice review out in #TheBreast summarizing the best and not-to-miss advancements in #breastcancer in 2023 Useful resource for all HCP! Proud to see cited here our work led by Matteo Lambertini, MD PhD on pregnancy after breast cancer in young BRCA carriers🤰🏼 OncoAlert thebreastonline.com/article/S0960-…

By 2050, cancer cases are projected to be 77% higher than they were in 2022. Growing & ageing populations are contributing to the alarming rise, as are risk factors like tobacco, obesity & air pollution - addressing these will help protect people against cancer #WorldCancerDay

This Sunday 4 February is #WorldCancerDay! According to our new global estimates, 5.4 million men and 4.3 million women died from cancer in 2022. Where you live should not determine if you live. Let's #ClosetheCareGap to reduce suffering from cancer across the 🌎🌍🌏

As we commit to beating Cancer on #WorldCancerDay a thread on ◇ #Cancercare in India ◇ National Cancer Registry Program #NCRP ◇ Delayed diagnosis and survival #CloseTheCareGap #CancerAwareness #CancerPrevention Dr Prashant Mathur ICMR IARC ncdirindia.org/display/wcd.as…

Very useful tables for easy reference. ADC in MBC . CDK inhibitors in MBC in first line . Cdk inhibitors after cdk inhibitors in MBC . PIK3CA/ Mtor / AKT inhibitors in MBC . Taken From article in The Breast Online By Ilana Schlam and by Dr Mariana Chavez -Macgregor 👍👍

The much awaited full publication of Ev plus pembrolizumab trial in advanced urothelial cancer. Double PFS and OS with HR of 0.47 for OS NEJM Great 👍 results . Median OS of 31.5 months . Questions remain about 1- excesss cost ( almost 4 times more costly in USA and

📑💊 Differences of CDK4/6 inhibitors JNCI ✅Preclinical ✔️Affinity to different CDKs ✔️Different effects on senescence and apoptosis ✔️These differences may affect efficacy, side effects and resistance ✅Clinical ➡️Metastatic ✔️Only ribociclib plus letrozole

Cure remains elusive term for metastatic cancer; keeping the scientific community on toes.Lack of palliative care and hospice care,however,is a bitter truth, more so in a society where families are nuclear. While we aim for moon, we must remain anchored to ground realities.

Let's prevent lung cancer with knowledge, awareness, and action. MoEF&CC EIACP ICMR-National Institute of Occupational Health ICMR Ministry of Health @GujHFWDept #LungCancerDay #LungCancerAwareness

Unless you make hospitals safe for doctors, nurses and other medical / paramedical staff, you'll soon end up not having access to healthcare. As an emerging economy, this is the least we should do. This should be non-negotiable. We've had empty promises for too long.

Montek LC was my go to anti sneeze medicine until last year..... I used to feel smarter for attacking physiological pathway than just treating symptoms. 😂 Stopped a while back after knowing better!

ASTRO abstracts are no longer embargoed after 5PM EST 9/27. Here is LBA1: PARTIQoL, Phase III study of protons vs IMRT for LR/IR prostate cancer. No significant differences in tumor control or patient-reported quality of life out to 60 months of follow up. #radonc

October is Breast Cancer Awareness Month. As a Clinical Dietitian and Cancer Caregiver, I promote cancer prevention and management. Follow these tips to reduce your risk of breast cancer: 1.Stay physically active. 2.Include soy products in your diet. 3. Maintain a healthy

I have a very personal connection to cancer, having witnessed it take away my loved ones. As a Clinical Dietitian and Cancer Nutritionist, I’m proud to help those affected by cancer. If you need any support, guidance, or assistance with cancer-related nutrition, please feel free

Wrapping up another fantastic #SABCS! Amazing, practice-changing data were presented. I’ve updated the algorithms and added key studies from the meeting— I finally ran out of space in HR+ disease! #SABCS24 OncoAlert

How blood looks under the microscope 🔬🩸

< 2 wks to #ASCO25, here is a📝 of 🔑abstracts for general onc that could guide our SoC! - #ATOMIC - #MATTERHORN - #SERENA6 - #ASCENT04 - #DestinyBreast09 - #IMforte & #Dellphi304 - Updates: #CM816 & #NIAGARA - #NIVOPOSTOP - #VERIFY #OncTwitter ASCO OncoAlert